ǥ :
|
ȣ - 520528 29 |
Patterns of Neointimal Coverage and Stent Malapposition in Acute Coronary Syndrome at 9 Months After Drug-Eluting Stents Implantation; Optical Coherence Tomography Findings |
연세대학교 신촌세브란스 병원 |
김중선, 이정명, 서용성, 김진선, 김웅, 백성일, 고영국, 최동훈, 장양수, 정남식 |
Background: Acute coronary syndrome (ACS) has a different pathophysiology from stable angina and the different pattern of neointmal hyperplasia (NIH) and malapposition. Therefore, we compared NIH pattern and malapposition at 9 months after implantation between ACS and non-ACS using OCT. Method: Optical coherence tomography (OCT) was performed at 9-month with 39 ACS (13 in sirolimus eluting stent (SES), 15 in Paclitaxel eluting stent (PES) and 11 in Zotarolimus eluting stent (ZES)) and 34 non-ACS (14 in SES, 10 in PES and 10 in ZES). NIH thickness, percent NIH area and rate of malaaposition were measured at each stent strut and corss section. Results: In total, 16398 struts in 1698-mm single-stented segments were analyzed. Overall, NIH thickness and percent NIH area were not different between ACS and non-ACS (173 ± 100 vs. 178 ± 137 μm, p = 0.602 and 21 ± 13 vs. 21 ± 11 %, p =0.940) and rates of malapposition and exposed struts were also not significantly different (2.1 vs. 0.5 %, p=0.118 and 5.0 vs. 2.4 %, 0.264). According to the type of stents, SES has different features according to presence of ACS compared to other 2 drug eluting stents (DESs, Table 1). Conclusion: Neointimal coverage and malapposition rate at 9-month after stent implantation was not significantly defferent between ACS and non-ACS. But, SES has somewhat different patterns of NIH. Therefore, present study suggested that neointimal coverage and malapposition might be influenced by type of DESs more than clinical presentation.
|
Table 1
|
|
ACS (n= 39) |
Non-ACS (n=34) |
p-value |
SES (n = 27) |
Malapposition (%) |
4.7 ± 9.0 |
0.09 ± 0.2 |
0.088 |
Exposed strut (%) |
12.8 ± 19.8 |
2.3 ± 4.6 |
0.158 |
PES (n = 21) |
Malapposition (%) |
1.5 ± 4.5 |
1.4 ± 4.0 |
0.334 |
Exposed strut (%) |
1.8 ± 1.8 |
4.8 ± 9.8 |
0.959 |
ZES (n = 25) |
Malapposition (%) |
0.2 ± 0.7 |
0.05 ± 0.1 |
0.480 |
Exposed strut (%) |
0.6 ± 1.7 |
0.0 ± 0.0 |
0.179 |
Stent Malapposition was defined as ≥ 160 μm for SES, ≥ 130 μm for PES and ≥ 110 μm for ZES.
|
|
|